Selected research
Market Outlook & Growth Opportunities
Global Anxiety Relief Supplements Market Outlook and Growth Opportunities 2026
Market perspective
The global Anxiety Relief Supplements market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Anxiety Relief Supplements is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Anxiety Relief Supplements is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Anxiety Relief Supplements is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Anxiety Relief Supplements market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Anxiety Relief Supplements market include LONZA, Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., Nestle S.A., Merck, The Nature's Bounty Co., Now Food, Nature's Sunshine and Herbalife, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Anxiety Relief Supplements market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Anxiety Relief Supplements and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Anxiety Relief Supplements sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Anxiety Relief Supplements market size, projected growth trends, production technologies, key applications, and end-use industries.
Anxiety Relief Supplements Segment by Company
LONZA
Takeda Pharmaceutical Co. Ltd.
Teva Pharmaceutical Industries Ltd.
Nestle S.A.
Merck
The Nature's Bounty Co.
Now Food
Nature's Sunshine
Herbalife
GNC
DuPont
DSM
Ayanda
Arkopharma
Amway Corporation
Abbott Laboratories
Anxiety Relief Supplements Segment by Type
Vitamin Supplements
Magnesium Supplements
L-Theanine Supplements
Other
Anxiety Relief Supplements Segment by Application
Clinic
Pharmacy
E-commerce Platform
Supermarket
Other
Anxiety Relief Supplements Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Anxiety Relief Supplements status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Anxiety Relief Supplements market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Anxiety Relief Supplements significant trends, drivers, influence factors in global and regions.
6. To analyze Anxiety Relief Supplements competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anxiety Relief Supplements market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Anxiety Relief Supplements and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anxiety Relief Supplements.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Anxiety Relief Supplements market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Anxiety Relief Supplements industry.
Chapter 3: Detailed analysis of Anxiety Relief Supplements manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Anxiety Relief Supplements in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Anxiety Relief Supplements in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
List of Tables
Table 1. Anxiety Relief Supplements Industry Trends
Table 2. Anxiety Relief Supplements Industry Drivers
Table 3. Anxiety Relief Supplements Industry Opportunities and Challenges
Table 4. Anxiety Relief Supplements Industry Restraints
Table 5. Global Anxiety Relief Supplements Revenue by Company (US$ Million) & (2021-2026)
Table 6. Global Anxiety Relief Supplements Revenue Share by Company (2021-2026)
Table 7. Global Anxiety Relief Supplements Sales Volume by Company (k units) & (2021-2026)
Table 8. Global Anxiety Relief Supplements Sales Volume Share by Company (2021-2026)
Table 9. Global Anxiety Relief Supplements Average Price (US$/unit) of Company (2021-2026)
Table 10. Global Anxiety Relief Supplements Company Ranking, (2024-2026) & (USD Million)
Table 11. Global Anxiety Relief Supplements Key Company Manufacturing Base & Headquarters
Table 12. Global Anxiety Relief Supplements Company, Product Type & Application
Table 13. Global Anxiety Relief Supplements Company Establishment Date
Table 14. Global Company Market Concentration Ratio (CR5 and HHI)
Table 15. Global Anxiety Relief Supplements by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025)
Table 16. Mergers & Acquisitions, Expansion
Table 17. Significant Companies of Vitamin Supplements
Table 18. Significant Companies of Magnesium Supplements
Table 19. Significant Companies of L-Theanine Supplements
Table 20. Significant Companies of Other
Table 21. Global Anxiety Relief Supplements Sales Volume by Type 2021 VS 2025 VS 2032 (k units)
Table 22. Global Anxiety Relief Supplements Sales Volume by Type (2021-2026) & (k units)
Table 23. Global Anxiety Relief Supplements Sales Volume by Type (2027-2032) & (k units)
Table 24. Global Anxiety Relief Supplements Sales Volume Share by Type (2021-2026)
Table 25. Global Anxiety Relief Supplements Sales Volume Share by Type (2027-2032)
Table 26. Global Anxiety Relief Supplements Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million)
Table 27. Global Anxiety Relief Supplements Sales Value by Type (2021-2026) & (US$ Million)
Table 28. Global Anxiety Relief Supplements Sales Value by Type (2027-2032) & (US$ Million)
Table 29. Global Anxiety Relief Supplements Sales Value Share by Type (2021-2026)
Table 30. Global Anxiety Relief Supplements Sales Value Share by Type (2027-2032)
Table 31. Significant Companies of Clinic
Table 32. Significant Companies of Pharmacy
Table 33. Significant Companies of E-commerce Platform
Table 34. Significant Companies of Supermarket
Table 35. Significant Companies of Other
Table 36. Global Anxiety Relief Supplements Sales Volume by Application 2021 VS 2025 VS 2032 (k units)
Table 37. Global Anxiety Relief Supplements Sales Volume by Application (2021-2026) & (k units)
Table 38. Global Anxiety Relief Supplements Sales Volume by Application (2027-2032) & (k units)
Table 39. Global Anxiety Relief Supplements Sales Volume Share by Application (2021-2026)
Table 40. Global Anxiety Relief Supplements Sales Volume Share by Application (2027-2032)
Table 41. Global Anxiety Relief Supplements Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million)
Table 42. Global Anxiety Relief Supplements Sales Value by Application (2021-2026) & (US$ Million)
Table 43. Global Anxiety Relief Supplements Sales Value by Application (2027-2032) & (US$ Million)
Table 44. Global Anxiety Relief Supplements Sales Value Share by Application (2021-2026)
Table 45. Global Anxiety Relief Supplements Sales Value Share by Application (2027-2032)
Table 46. Global Anxiety Relief Supplements Sales by Region: 2021 VS 2025 VS 2032 (k units)
Table 47. Global Anxiety Relief Supplements Sales by Region (2021-2026) & (k units)
Table 48. Global Anxiety Relief Supplements Sales Market Share by Region (2021-2026)
Table 49. Global Anxiety Relief Supplements Sales by Region (2027-2032) & (k units)
Table 50. Global Anxiety Relief Supplements Sales Market Share by Region (2027-2032)
Table 51. Global Anxiety Relief Supplements Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
Table 52. Global Anxiety Relief Supplements Sales Value by Region (2021-2026) & (US$ Million)
Table 53. Global Anxiety Relief Supplements Sales Value Share by Region (2021-2026)
Table 54. Global Anxiety Relief Supplements Sales Value by Region (2027-2032) & (US$ Million)
Table 55. Global Anxiety Relief Supplements Sales Value Share by Region (2027-2032)
Table 56. Global Anxiety Relief Supplements Market Average Price (US$/unit) by Region (2021-2026)
Table 57. Global Anxiety Relief Supplements Market Average Price (US$/unit) by Region (2027-2032)
Table 58. Global Anxiety Relief Supplements Sales by Country: 2021 VS 2025 VS 2032 (k units)
Table 59. Global Anxiety Relief Supplements Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 60. Global Anxiety Relief Supplements Sales by Country (2021-2026) & (k units)
Table 61. Global Anxiety Relief Supplements Sales Market Share by Country (2021-2026)
Table 62. Global Anxiety Relief Supplements Sales by Country (2027-2032) & (k units)
Table 63. Global Anxiety Relief Supplements Sales Market Share by Country (2027-2032)
Table 64. Global Anxiety Relief Supplements Sales Value by Country (2021-2026) & (US$ Million)
Table 65. Global Anxiety Relief Supplements Sales Value Market Share by Country (2021-2026)
Table 66. Global Anxiety Relief Supplements Sales Value by Country (2027-2032) & (US$ Million)
Table 67. Global Anxiety Relief Supplements Sales Value Market Share by Country (2027-2032)
Table 68. LONZA Company Information
Table 69. LONZA Business Overview
Table 70. LONZA Anxiety Relief Supplements Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026)
Table 71. LONZA Anxiety Relief Supplements Product Portfolio
Table 72. LONZA Recent Development
Table 73. Takeda Pharmaceutical Co. Ltd. Company Information
Table 74. Takeda Pharmaceutical Co. Ltd. Business Overview
Table 75. Takeda Pharmaceutical Co. Ltd. Anxiety Relief Supplements Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026)
Table 76. Takeda Pharmaceutical Co. Ltd. Anxiety Relief Supplements Product Portfolio
Table 77. Takeda Pharmaceutical Co. Ltd. Recent Development
Table 78. Teva Pharmaceutical Industries Ltd. Company Information
Table 79. Teva Pharmaceutical Industries Ltd. Business Overview
Table 80. Teva Pharmaceutical Industries Ltd. Anxiety Relief Supplements Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026)
Table 81. Teva Pharmaceutical Industries Ltd. Anxiety Relief Supplements Product Portfolio
Table 82. Teva Pharmaceutical Industries Ltd. Recent Development
Table 83. Nestle S.A. Company Information
Table 84. Nestle S.A. Business Overview
Table 85. Nestle S.A. Anxiety Relief Supplements Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026)
Table 86. Nestle S.A. Anxiety Relief Supplements Product Portfolio
Table 87. Nestle S.A. Recent Development
Table 88. Merck Company Information
Table 89. Merck Business Overview
Table 90. Merck Anxiety Relief Supplements Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026)
Table 91. Merck Anxiety Relief Supplements Product Portfolio
Table 92. Merck Recent Development
Table 93. The Nature's Bounty Co. Company Information
Table 94. The Nature's Bounty Co. Business Overview
Table 95. The Nature's Bounty Co. Anxiety Relief Supplements Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026)
Table 96. The Nature's Bounty Co. Anxiety Relief Supplements Product Portfolio
Table 97. The Nature's Bounty Co. Recent Development
Table 98. Now Food Company Information
Table 99. Now Food Business Overview
Table 100. Now Food Anxiety Relief Supplements Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026)
Table 101. Now Food Anxiety Relief Supplements Product Portfolio
Table 102. Now Food Recent Development
Table 103. Nature's Sunshine Company Information
Table 104. Nature's Sunshine Business Overview
Table 105. Nature's Sunshine Anxiety Relief Supplements Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026)
Table 106. Nature's Sunshine Anxiety Relief Supplements Product Portfolio
Table 107. Nature's Sunshine Recent Development
Table 108. Herbalife Company Information
Table 109. Herbalife Business Overview
Table 110. Herbalife Anxiety Relief Supplements Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026)
Table 111. Herbalife Anxiety Relief Supplements Product Portfolio
Table 112. Herbalife Recent Development
Table 113. GNC Company Information
Table 114. GNC Business Overview
Table 115. GNC Anxiety Relief Supplements Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026)
Table 116. GNC Anxiety Relief Supplements Product Portfolio
Table 117. GNC Recent Development
Table 118. DuPont Company Information
Table 119. DuPont Business Overview
Table 120. DuPont Anxiety Relief Supplements Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026)
Table 121. DuPont Anxiety Relief Supplements Product Portfolio
Table 122. DuPont Recent Development
Table 123. DSM Company Information
Table 124. DSM Business Overview
Table 125. DSM Anxiety Relief Supplements Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026)
Table 126. DSM Anxiety Relief Supplements Product Portfolio
Table 127. DSM Recent Development
Table 128. Ayanda Company Information
Table 129. Ayanda Business Overview
Table 130. Ayanda Anxiety Relief Supplements Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026)
Table 131. Ayanda Anxiety Relief Supplements Product Portfolio
Table 132. Ayanda Recent Development
Table 133. Arkopharma Company Information
Table 134. Arkopharma Business Overview
Table 135. Arkopharma Anxiety Relief Supplements Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026)
Table 136. Arkopharma Anxiety Relief Supplements Product Portfolio
Table 137. Arkopharma Recent Development
Table 138. Amway Corporation Company Information
Table 139. Amway Corporation Business Overview
Table 140. Amway Corporation Anxiety Relief Supplements Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026)
Table 141. Amway Corporation Anxiety Relief Supplements Product Portfolio
Table 142. Amway Corporation Recent Development
Table 143. Abbott Laboratories Company Information
Table 144. Abbott Laboratories Business Overview
Table 145. Abbott Laboratories Anxiety Relief Supplements Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026)
Table 146. Abbott Laboratories Anxiety Relief Supplements Product Portfolio
Table 147. Abbott Laboratories Recent Development
Table 148. Key Raw Materials
Table 149. Raw Materials Key Suppliers
Table 150. Anxiety Relief Supplements Distributors List
Table 151. Anxiety Relief Supplements Customers List
Table 152. Research Programs/Design for This Report
Table 153. Authors List of This Report
Table 154. Secondary Sources
Table 155. Primary Sources
List of Figures
Figure 1. Anxiety Relief Supplements Product Image
Figure 2. Global Anxiety Relief Supplements Sales Value (US$ Million), 2021 VS 2025 VS 2032
Figure 3. Global Anxiety Relief Supplements Sales Value (2021-2032) & (US$ Million)
Figure 4. Global Anxiety Relief Supplements Sales (2021-2032) & (k units)
Figure 5. Global Anxiety Relief Supplements Sales Average Price (US$/unit) & (2021-2032)
Figure 6. Global Anxiety Relief Supplements Company Revenue Ranking in 2025 (US$ Million)
Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million)
Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 9. Vitamin Supplements Image
Figure 10. Magnesium Supplements Image
Figure 11. L-Theanine Supplements Image
Figure 12. Other Image
Figure 13. Global Anxiety Relief Supplements Sales Volume by Type (2021 VS 2025 VS 2032) & (k units)
Figure 14. Global Anxiety Relief Supplements Sales Volume Share 2021 VS 2025 VS 2032
Figure 15. Global Anxiety Relief Supplements Sales Volume Share by Type (2021-2032)
Figure 16. Global Anxiety Relief Supplements Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 17. Global Anxiety Relief Supplements Sales Value Share 2021 VS 2025 VS 2032
Figure 18. Global Anxiety Relief Supplements Sales Value Share by Type (2021-2032)
Figure 19. Clinic Image
Figure 20. Pharmacy Image
Figure 21. E-commerce Platform Image
Figure 22. Supermarket Image
Figure 23. Other Image
Figure 24. Global Anxiety Relief Supplements Sales Volume by Application (2021 VS 2025 VS 2032) & (k units)
Figure 25. Global Anxiety Relief Supplements Sales Volume Share 2021 VS 2025 VS 2032
Figure 26. Global Anxiety Relief Supplements Sales Volume Share by Application (2021-2032)
Figure 27. Global Anxiety Relief Supplements Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 28. Global Anxiety Relief Supplements Sales Value Share 2021 VS 2025 VS 2032
Figure 29. Global Anxiety Relief Supplements Sales Value Share by Application (2021-2032)
Figure 30. Global Anxiety Relief Supplements Sales by Region: 2021 VS 2025 VS 2032 (k units)
Figure 31. Global Anxiety Relief Supplements Sales Market Share by Region: 2021 VS 2025 VS 2032
Figure 32. Global Anxiety Relief Supplements Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
Figure 33. Global Anxiety Relief Supplements Sales Value Share by Region: 2021 VS 2025 VS 2032
Figure 34. North America Anxiety Relief Supplements Sales Value (2021-2032) & (US$ Million)
Figure 35. North America Anxiety Relief Supplements Sales Value Share by Country (%), 2025 VS 2032
Figure 36. Europe Anxiety Relief Supplements Sales Value (2021-2032) & (US$ Million)
Figure 37. Europe Anxiety Relief Supplements Sales Value Share by Country (%), 2025 VS 2032
Figure 38. Asia-Pacific Anxiety Relief Supplements Sales Value (2021-2032) & (US$ Million)
Figure 39. Asia-Pacific Anxiety Relief Supplements Sales Value Share by Country (%), 2025 VS 2032
Figure 40. South America Anxiety Relief Supplements Sales Value (2021-2032) & (US$ Million)
Figure 41. South America Anxiety Relief Supplements Sales Value Share by Country (%), 2025 VS 2032
Figure 42. Middle East & Africa Anxiety Relief Supplements Sales Value (2021-2032) & (US$ Million)
Figure 43. Middle East & Africa Anxiety Relief Supplements Sales Value Share by Country (%), 2025 VS 2032
Figure 44. USA Anxiety Relief Supplements Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 45. USA Anxiety Relief Supplements Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 46. USA Anxiety Relief Supplements Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 47. Canada Anxiety Relief Supplements Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 48. Canada Anxiety Relief Supplements Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 49. Canada Anxiety Relief Supplements Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 50. Mexico Anxiety Relief Supplements Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 51. Mexico Anxiety Relief Supplements Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 52. Mexico Anxiety Relief Supplements Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 53. Germany Anxiety Relief Supplements Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 54. Germany Anxiety Relief Supplements Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 55. Germany Anxiety Relief Supplements Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 56. France Anxiety Relief Supplements Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 57. France Anxiety Relief Supplements Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 58. France Anxiety Relief Supplements Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 59. U.K. Anxiety Relief Supplements Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 60. U.K. Anxiety Relief Supplements Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 61. U.K. Anxiety Relief Supplements Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 62. Italy Anxiety Relief Supplements Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 63. Italy Anxiety Relief Supplements Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 64. Italy Anxiety Relief Supplements Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 65. Spain Anxiety Relief Supplements Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 66. Spain Anxiety Relief Supplements Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 67. Spain Anxiety Relief Supplements Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 68. Russia Anxiety Relief Supplements Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 69. Russia Anxiety Relief Supplements Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 70. Russia Anxiety Relief Supplements Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 71. Netherlands Anxiety Relief Supplements Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 72. Netherlands Anxiety Relief Supplements Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 73. Netherlands Anxiety Relief Supplements Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 74. Nordic Countries Anxiety Relief Supplements Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 75. Nordic Countries Anxiety Relief Supplements Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 76. Nordic Countries Anxiety Relief Supplements Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 77. China Anxiety Relief Supplements Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 78. China Anxiety Relief Supplements Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 79. China Anxiety Relief Supplements Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 80. Japan Anxiety Relief Supplements Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 81. Japan Anxiety Relief Supplements Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 82. Japan Anxiety Relief Supplements Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 83. South Korea Anxiety Relief Supplements Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 84. South Korea Anxiety Relief Supplements Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 85. South Korea Anxiety Relief Supplements Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 86. India Anxiety Relief Supplements Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 87. India Anxiety Relief Supplements Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 88. India Anxiety Relief Supplements Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 89. Australia Anxiety Relief Supplements Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 90. Australia Anxiety Relief Supplements Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 91. Australia Anxiety Relief Supplements Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 92. Southeast Asia Anxiety Relief Supplements Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 93. Southeast Asia Anxiety Relief Supplements Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 94. Southeast Asia Anxiety Relief Supplements Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 95. Brazil Anxiety Relief Supplements Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 96. Brazil Anxiety Relief Supplements Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 97. Brazil Anxiety Relief Supplements Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 98. Argentina Anxiety Relief Supplements Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 99. Argentina Anxiety Relief Supplements Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 100. Argentina Anxiety Relief Supplements Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 101. Chile Anxiety Relief Supplements Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 102. Chile Anxiety Relief Supplements Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 103. Chile Anxiety Relief Supplements Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 104. Colombia Anxiety Relief Supplements Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 105. Colombia Anxiety Relief Supplements Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 106. Colombia Anxiety Relief Supplements Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 107. Peru Anxiety Relief Supplements Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 108. Peru Anxiety Relief Supplements Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 109. Peru Anxiety Relief Supplements Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 110. Saudi Arabia Anxiety Relief Supplements Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 111. Saudi Arabia Anxiety Relief Supplements Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 112. Saudi Arabia Anxiety Relief Supplements Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 113. Israel Anxiety Relief Supplements Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 114. Israel Arabia Anxiety Relief Supplements Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 115. Israel Arabia Anxiety Relief Supplements Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 116. UAE Anxiety Relief Supplements Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 117. UAE Anxiety Relief Supplements Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 118. UAE Anxiety Relief Supplements Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 119. Turkey Anxiety Relief Supplements Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 120. Turkey Anxiety Relief Supplements Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 121. Turkey Anxiety Relief Supplements Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 122. Iran Anxiety Relief Supplements Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 123. Iran Anxiety Relief Supplements Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 124. Iran Anxiety Relief Supplements Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 125. Egypt Anxiety Relief Supplements Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 126. Egypt Anxiety Relief Supplements Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 127. Egypt Anxiety Relief Supplements Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 128. Anxiety Relief Supplements Value Chain
Figure 129. Manufacturing Cost Structure
Figure 130. Anxiety Relief Supplements Sales Mode & Process
Figure 131. Direct Comparison with Distribution Share
Figure 132. Distributors Profiles
Figure 133. Years Considered
Figure 134. Research Process
Figure 135. Key Executives Interviewed
Scope & coverage.
Types
- Vitamin Supplements
- Magnesium Supplements
- L-Theanine Supplements
- Other
Applications
- Clinic
- Pharmacy
- E-commerce Platform
- Supermarket
- Other
Companies covered
- LONZA
- Takeda Pharmaceutical Co. Ltd.
- Teva Pharmaceutical Industries Ltd.
- Nestle S.A.
- Merck
- The Nature's Bounty Co.
- Now Food
- Nature's Sunshine
- Herbalife
- GNC
- DuPont
- DSM
- Ayanda
- Arkopharma
- Amway Corporation
- Abbott Laboratories
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Anxiety Relief Supplements Sales Value (2021-2032)
- 1.2.2 Global Anxiety Relief Supplements Sales Volume (2021-2032)
- 1.2.3 Global Anxiety Relief Supplements Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Anxiety Relief Supplements Market Dynamics
- 2.1 Anxiety Relief Supplements Industry Trends
- 2.2 Anxiety Relief Supplements Industry Drivers
- 2.3 Anxiety Relief Supplements Industry Opportunities and Challenges
- 2.4 Anxiety Relief Supplements Industry Restraints
3 Anxiety Relief Supplements Market by Company
- 3.1 Global Anxiety Relief Supplements Company Revenue Ranking in 2025
- 3.2 Global Anxiety Relief Supplements Revenue by Company (2021-2026)
- 3.3 Global Anxiety Relief Supplements Sales Volume by Company (2021-2026)
- 3.4 Global Anxiety Relief Supplements Average Price by Company (2021-2026)
- 3.5 Global Anxiety Relief Supplements Company Ranking (2024-2026)
- 3.6 Global Anxiety Relief Supplements Company Manufacturing Base and Headquarters
- 3.7 Global Anxiety Relief Supplements Company Product Type and Application
- 3.8 Global Anxiety Relief Supplements Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Anxiety Relief Supplements Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Anxiety Relief Supplements Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Anxiety Relief Supplements Market by Type
- 4.1 Anxiety Relief Supplements Type Introduction
- 4.1.1 Vitamin Supplements
- 4.1.2 Magnesium Supplements
- 4.1.3 L-Theanine Supplements
- 4.1.4 Other
- 4.2 Global Anxiety Relief Supplements Sales Volume by Type
- 4.2.1 Global Anxiety Relief Supplements Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Anxiety Relief Supplements Sales Volume by Type (2021-2032)
- 4.2.3 Global Anxiety Relief Supplements Sales Volume Share by Type (2021-2032)
- 4.3 Global Anxiety Relief Supplements Sales Value by Type
- 4.3.1 Global Anxiety Relief Supplements Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Anxiety Relief Supplements Sales Value by Type (2021-2032)
- 4.3.3 Global Anxiety Relief Supplements Sales Value Share by Type (2021-2032)
5 Anxiety Relief Supplements Market by Application
- 5.1 Anxiety Relief Supplements Application Introduction
- 5.1.1 Clinic
- 5.1.2 Pharmacy
- 5.1.3 E-commerce Platform
- 5.1.4 Supermarket
- 5.1.5 Other
- 5.2 Global Anxiety Relief Supplements Sales Volume by Application
- 5.2.1 Global Anxiety Relief Supplements Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Anxiety Relief Supplements Sales Volume by Application (2021-2032)
- 5.2.3 Global Anxiety Relief Supplements Sales Volume Share by Application (2021-2032)
- 5.3 Global Anxiety Relief Supplements Sales Value by Application
- 5.3.1 Global Anxiety Relief Supplements Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Anxiety Relief Supplements Sales Value by Application (2021-2032)
- 5.3.3 Global Anxiety Relief Supplements Sales Value Share by Application (2021-2032)
6 Anxiety Relief Supplements Regional Sales and Value Analysis
- 6.1 Global Anxiety Relief Supplements Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Anxiety Relief Supplements Sales by Region (2021-2032)
- 6.2.1 Global Anxiety Relief Supplements Sales by Region: 2021-2026
- 6.2.2 Global Anxiety Relief Supplements Sales by Region (2027-2032)
- 6.3 Global Anxiety Relief Supplements Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Anxiety Relief Supplements Sales Value by Region (2021-2032)
- 6.4.1 Global Anxiety Relief Supplements Sales Value by Region: 2021-2026
- 6.4.2 Global Anxiety Relief Supplements Sales Value by Region (2027-2032)
- 6.5 Global Anxiety Relief Supplements Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Anxiety Relief Supplements Sales Value (2021-2032)
- 6.6.2 North America Anxiety Relief Supplements Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Anxiety Relief Supplements Sales Value (2021-2032)
- 6.7.2 Europe Anxiety Relief Supplements Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Anxiety Relief Supplements Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Anxiety Relief Supplements Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Anxiety Relief Supplements Sales Value (2021-2032)
- 6.9.2 South America Anxiety Relief Supplements Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Anxiety Relief Supplements Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Anxiety Relief Supplements Sales Value Share by Country, 2025 VS 2032
7 Anxiety Relief Supplements Country-level Sales and Value Analysis
- 7.1 Global Anxiety Relief Supplements Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Anxiety Relief Supplements Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Anxiety Relief Supplements Sales by Country (2021-2032)
- 7.3.1 Global Anxiety Relief Supplements Sales by Country (2021-2026)
- 7.3.2 Global Anxiety Relief Supplements Sales by Country (2027-2032)
- 7.4 Global Anxiety Relief Supplements Sales Value by Country (2021-2032)
- 7.4.1 Global Anxiety Relief Supplements Sales Value by Country (2021-2026)
- 7.4.2 Global Anxiety Relief Supplements Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Anxiety Relief Supplements Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Anxiety Relief Supplements Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Anxiety Relief Supplements Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Anxiety Relief Supplements Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Anxiety Relief Supplements Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Anxiety Relief Supplements Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Anxiety Relief Supplements Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Anxiety Relief Supplements Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Anxiety Relief Supplements Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Anxiety Relief Supplements Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Anxiety Relief Supplements Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Anxiety Relief Supplements Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Anxiety Relief Supplements Sales Value Growth Rate (2021-2032)
- 7.9.2 France Anxiety Relief Supplements Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Anxiety Relief Supplements Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Anxiety Relief Supplements Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Anxiety Relief Supplements Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Anxiety Relief Supplements Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Anxiety Relief Supplements Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Anxiety Relief Supplements Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Anxiety Relief Supplements Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Anxiety Relief Supplements Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Anxiety Relief Supplements Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Anxiety Relief Supplements Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Anxiety Relief Supplements Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Anxiety Relief Supplements Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Anxiety Relief Supplements Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Anxiety Relief Supplements Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Anxiety Relief Supplements Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Anxiety Relief Supplements Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Anxiety Relief Supplements Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Anxiety Relief Supplements Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Anxiety Relief Supplements Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Anxiety Relief Supplements Sales Value Growth Rate (2021-2032)
- 7.16.2 China Anxiety Relief Supplements Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Anxiety Relief Supplements Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Anxiety Relief Supplements Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Anxiety Relief Supplements Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Anxiety Relief Supplements Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Anxiety Relief Supplements Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Anxiety Relief Supplements Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Anxiety Relief Supplements Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Anxiety Relief Supplements Sales Value Growth Rate (2021-2032)
- 7.19.2 India Anxiety Relief Supplements Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Anxiety Relief Supplements Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Anxiety Relief Supplements Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Anxiety Relief Supplements Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Anxiety Relief Supplements Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Anxiety Relief Supplements Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Anxiety Relief Supplements Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Anxiety Relief Supplements Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Anxiety Relief Supplements Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Anxiety Relief Supplements Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Anxiety Relief Supplements Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Anxiety Relief Supplements Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Anxiety Relief Supplements Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Anxiety Relief Supplements Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Anxiety Relief Supplements Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Anxiety Relief Supplements Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Anxiety Relief Supplements Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Anxiety Relief Supplements Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Anxiety Relief Supplements Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Anxiety Relief Supplements Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Anxiety Relief Supplements Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Anxiety Relief Supplements Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Anxiety Relief Supplements Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Anxiety Relief Supplements Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Anxiety Relief Supplements Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Anxiety Relief Supplements Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Anxiety Relief Supplements Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Anxiety Relief Supplements Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Anxiety Relief Supplements Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Anxiety Relief Supplements Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Anxiety Relief Supplements Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Anxiety Relief Supplements Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Anxiety Relief Supplements Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Anxiety Relief Supplements Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Anxiety Relief Supplements Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Anxiety Relief Supplements Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Anxiety Relief Supplements Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Anxiety Relief Supplements Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Anxiety Relief Supplements Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Anxiety Relief Supplements Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Anxiety Relief Supplements Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 LONZA
- 8.1.1 LONZA Company Information
- 8.1.2 LONZA Business Overview
- 8.1.3 LONZA Anxiety Relief Supplements Sales, Value and Gross Margin (2021-2026)
- 8.1.4 LONZA Anxiety Relief Supplements Product Portfolio
- 8.1.5 LONZA Recent Developments
- 8.2 Takeda Pharmaceutical Co. Ltd.
- 8.2.1 Takeda Pharmaceutical Co. Ltd. Company Information
- 8.2.2 Takeda Pharmaceutical Co. Ltd. Business Overview
- 8.2.3 Takeda Pharmaceutical Co. Ltd. Anxiety Relief Supplements Sales, Value and Gross Margin (2021-2026)
- 8.2.4 Takeda Pharmaceutical Co. Ltd. Anxiety Relief Supplements Product Portfolio
- 8.2.5 Takeda Pharmaceutical Co. Ltd. Recent Developments
- 8.3 Teva Pharmaceutical Industries Ltd.
- 8.3.1 Teva Pharmaceutical Industries Ltd. Company Information
- 8.3.2 Teva Pharmaceutical Industries Ltd. Business Overview
- 8.3.3 Teva Pharmaceutical Industries Ltd. Anxiety Relief Supplements Sales, Value and Gross Margin (2021-2026)
- 8.3.4 Teva Pharmaceutical Industries Ltd. Anxiety Relief Supplements Product Portfolio
- 8.3.5 Teva Pharmaceutical Industries Ltd. Recent Developments
- 8.4 Nestle S.A.
- 8.4.1 Nestle S.A. Company Information
- 8.4.2 Nestle S.A. Business Overview
- 8.4.3 Nestle S.A. Anxiety Relief Supplements Sales, Value and Gross Margin (2021-2026)
- 8.4.4 Nestle S.A. Anxiety Relief Supplements Product Portfolio
- 8.4.5 Nestle S.A. Recent Developments
- 8.5 Merck
- 8.5.1 Merck Company Information
- 8.5.2 Merck Business Overview
- 8.5.3 Merck Anxiety Relief Supplements Sales, Value and Gross Margin (2021-2026)
- 8.5.4 Merck Anxiety Relief Supplements Product Portfolio
- 8.5.5 Merck Recent Developments
- 8.6 The Nature's Bounty Co.
- 8.6.1 The Nature's Bounty Co. Company Information
- 8.6.2 The Nature's Bounty Co. Business Overview
- 8.6.3 The Nature's Bounty Co. Anxiety Relief Supplements Sales, Value and Gross Margin (2021-2026)
- 8.6.4 The Nature's Bounty Co. Anxiety Relief Supplements Product Portfolio
- 8.6.5 The Nature's Bounty Co. Recent Developments
- 8.7 Now Food
- 8.7.1 Now Food Company Information
- 8.7.2 Now Food Business Overview
- 8.7.3 Now Food Anxiety Relief Supplements Sales, Value and Gross Margin (2021-2026)
- 8.7.4 Now Food Anxiety Relief Supplements Product Portfolio
- 8.7.5 Now Food Recent Developments
- 8.8 Nature's Sunshine
- 8.8.1 Nature's Sunshine Company Information
- 8.8.2 Nature's Sunshine Business Overview
- 8.8.3 Nature's Sunshine Anxiety Relief Supplements Sales, Value and Gross Margin (2021-2026)
- 8.8.4 Nature's Sunshine Anxiety Relief Supplements Product Portfolio
- 8.8.5 Nature's Sunshine Recent Developments
- 8.9 Herbalife
- 8.9.1 Herbalife Company Information
- 8.9.2 Herbalife Business Overview
- 8.9.3 Herbalife Anxiety Relief Supplements Sales, Value and Gross Margin (2021-2026)
- 8.9.4 Herbalife Anxiety Relief Supplements Product Portfolio
- 8.9.5 Herbalife Recent Developments
- 8.10 GNC
- 8.10.1 GNC Company Information
- 8.10.2 GNC Business Overview
- 8.10.3 GNC Anxiety Relief Supplements Sales, Value and Gross Margin (2021-2026)
- 8.10.4 GNC Anxiety Relief Supplements Product Portfolio
- 8.10.5 GNC Recent Developments
- 8.11 DuPont
- 8.11.1 DuPont Company Information
- 8.11.2 DuPont Business Overview
- 8.11.3 DuPont Anxiety Relief Supplements Sales, Value and Gross Margin (2021-2026)
- 8.11.4 DuPont Anxiety Relief Supplements Product Portfolio
- 8.11.5 DuPont Recent Developments
- 8.12 DSM
- 8.12.1 DSM Company Information
- 8.12.2 DSM Business Overview
- 8.12.3 DSM Anxiety Relief Supplements Sales, Value and Gross Margin (2021-2026)
- 8.12.4 DSM Anxiety Relief Supplements Product Portfolio
- 8.12.5 DSM Recent Developments
- 8.13 Ayanda
- 8.13.1 Ayanda Company Information
- 8.13.2 Ayanda Business Overview
- 8.13.3 Ayanda Anxiety Relief Supplements Sales, Value and Gross Margin (2021-2026)
- 8.13.4 Ayanda Anxiety Relief Supplements Product Portfolio
- 8.13.5 Ayanda Recent Developments
- 8.14 Arkopharma
- 8.14.1 Arkopharma Company Information
- 8.14.2 Arkopharma Business Overview
- 8.14.3 Arkopharma Anxiety Relief Supplements Sales, Value and Gross Margin (2021-2026)
- 8.14.4 Arkopharma Anxiety Relief Supplements Product Portfolio
- 8.14.5 Arkopharma Recent Developments
- 8.15 Amway Corporation
- 8.15.1 Amway Corporation Company Information
- 8.15.2 Amway Corporation Business Overview
- 8.15.3 Amway Corporation Anxiety Relief Supplements Sales, Value and Gross Margin (2021-2026)
- 8.15.4 Amway Corporation Anxiety Relief Supplements Product Portfolio
- 8.15.5 Amway Corporation Recent Developments
- 8.16 Abbott Laboratories
- 8.16.1 Abbott Laboratories Company Information
- 8.16.2 Abbott Laboratories Business Overview
- 8.16.3 Abbott Laboratories Anxiety Relief Supplements Sales, Value and Gross Margin (2021-2026)
- 8.16.4 Abbott Laboratories Anxiety Relief Supplements Product Portfolio
- 8.16.5 Abbott Laboratories Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Anxiety Relief Supplements Value Chain Analysis
- 9.1.1 Anxiety Relief Supplements Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Anxiety Relief Supplements Sales Mode & Process
- 9.2 Anxiety Relief Supplements Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Anxiety Relief Supplements Distributors
- 9.2.3 Anxiety Relief Supplements Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$4,250USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst